Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biocept Inc (BIOC)

  7. Biocept Inc (BIOC) News

BIOC

Biocept Inc
0.292
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Biocept Inc BIOC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 0.292 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.292
more quote information »

Recent News

Date Time Source Heading
3/24/202308:00BWEnrollment Begins in FORESEE Clinical Trial Using Biocept’s..
3/20/202308:01EDGARCurrent Report Filing (8-k)
3/01/202308:00BWBiocept Reports Inducement Grants Under Nasdaq Listing Rule..
1/06/202307:02EDGARCurrent Report Filing (8-k)
1/06/202306:55BWBiocept to Explore Strategic Alternatives and Implement..
11/21/202216:12EDGARQuarterly Report (10-q)
11/21/202216:05BWBiocept Reports Third Quarter 2022 Financial Results
11/18/202208:00BWBiocept Appoints Financial Executive Quyen Dao-Haddock to..
11/16/202208:00BWBiocept Announces Participation in an Investigator-Initiated..
11/14/202217:30EDGARNotification That Quarterly Report Will Be Submitted Late..
11/14/202208:02EDGARCurrent Report Filing (8-k)
11/12/202211:45TRMNMaxim Group Remains a Buy on Biocept (BIOC)
11/10/202216:26EDGARQuarterly Report (10-q)
11/10/202216:05BWBiocept Reports Second Quarter 2022 Financial Results
10/19/202216:07EDGARCurrent Report Filing (8-k)
10/19/202208:00BWBiocept to Present at the LD Micro Main Event XV
10/17/202208:00BWBiocept Expands Commercial Offering of CNSide™ Assay to Most..
10/14/202208:00BWBiocept to Host KOL Webinar Today to Discuss its Proprietary..
10/06/202208:00BWBiocept to Host Key Opinion Leader Webinar on October 14 to..
9/08/202214:43EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202214:39EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202214:39EDGARStatement of Changes in Beneficial Ownership (4)
9/08/202214:33EDGARStatement of Changes in Beneficial Ownership (4)
8/31/202216:31BWBiocept Reports Inducement Grants Under Nasdaq Listing Rule..
8/22/202216:35EDGARCurrent Report Filing (8-k)
8/22/202216:15BWBiocept Announces Receipt of Deficiency Notice from Nasdaq..
8/16/202208:06EDGARNotification That Quarterly Report Will Be Submitted Late..
8/16/202208:00BWBiocept Announces a Delay in the Filing of its Quarterly..
7/14/202206:09EDGARCurrent Report Filing (8-k)
7/13/202216:04EDGARCurrent Report Filing (8-k)
6/27/202216:06EDGARCurrent Report Filing (8-k)
6/27/202208:00BWBiocept Appoints RSM as Independent Auditor
6/22/202207:30GLOBEPlus Therapeutics and Biocept Announce Comprehensive..
6/13/202216:07EDGARCurrent Report Filing (8-k)
6/13/202216:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/07/202208:00BWBiocept to Hold Business Strategy Conference Call Today
5/23/202216:05BWBiocept Reports First Quarter 2022 Financial Results
5/16/202216:57EDGARNotification That Quarterly Report Will Be Submitted Late..
5/16/202216:05BWBiocept Announces a Delay in the Filing of its Quarterly..
4/27/202214:55TRMNBiocept (BIOC) Receives a Buy from Brookline Capital Markets
4/12/202216:03EDGARCurrent Report Filing (8-k)
4/08/202217:20EDGARSecurities Registration: Employee Benefit Plan (s-8)
4/08/202216:05BWBiocept Reports Inducement Grants Under Nasdaq Listing Rule..
4/08/202208:45TRMNMaxim Group Thinks Biocept’s Stock is Going to Recover
4/07/202206:08EDGARCurrent Report Filing (8-k)
4/06/202208:00BWBiocept Reports 2021 Fourth Quarter and Full Year Financial..
4/05/202217:27EDGARAnnual Report (10-k)
4/04/202214:38EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202214:25EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202216:05EDGARCurrent Report Filing (8-k)